BIOMEDICAL JOURNAL OF PIROGOV RNRMU (MOSCOW, RUSSIA)
Issue 4, 2018
The lack of a unified biohazard monitoring center is a factor of society vulnerability. The national biohazard monitoring system could be the basis for the nationwide biosecurity service and at the same time a means of identifying and addressing its own vulnerabilities. The topic publications describe the elements of a national system for biological threats monitoring, pointing out the features of the operation of equipment during practical trials.
Issue 5, 2017
Our immune system is capable of “remembering” pathogens. This phenomenon is exploited to establish protection against infection by vaccination. Vladimir Guschin of Gamaleya Research Institute of Epidemiology and Microbiology (Moscow) et al. describe the contemporary approaches to studying population immunity, propose a system for serological surveillance in Russia and in the original research report the first results of the clinical trial of GamTBvac, a candidate recombinant vaccine against tuberculosis. Ekaterina Merzlyak of the Institute of Bioorganic Chemistry et al. study the repertoires of T-cell receptors in patients with autoimmune vasculitis following treatment with cyclophosphamide.
Issue 6, 2017Rehabilitation is one of the most crucial stages in the therapy of many diseases. The quality of the patient's further life largely depends on the quality of rehabilitation. The issue discusses rehabilitation in medicine in the context of sports injuries. Also, several important works in the field of oncology, immunology, physiology and hygiene were published.
Issue 1, 2018For almost 100 years now, mankind has been fighting incessantly against pathogenic bacteria with the help of more and more new antibiotics. But evolutionary flexibility allows pathogens to bypass our locks almost at the speed of the invention. One of the good alternatives to speeding up and reducing the cost of this arms race is the bacteriophage.
Issue 2, 2018
Сomplex genomes editing with CRISPR-Cas systems is the most promising approach to introduce exact changes in DNA in vivo, both in scientific applications and in medicine. The diversity of CRISPR-Cas systems (protecting the bacterium from a virus attack) allowed researchers to deduce a wide range of enzymes with various properties for the lab applications. However, the new genome editing systems investigation is unstoppable and in the near future we will see CRISPR-Cas systems with new characteristics of efficiency and accuracy.
Issue 3, 2018
The long-term use of a wide range of antibiotics led to the appearance of drug-resistant and highly virulent strains of Mycobacterium tuberculosis. The effectiveness of treatment of such forms with multiple and broad drug resistance depends not only on the use of new drugs, but also on the patient's immune status and the composition of its microbiota. In this regard, the development of vaccines, adjuvants and probiotics with selective immunomodulating and antioxidant properties is gaining new importance.